Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Top Stock Analyzer
(Total Views: 154)
Posted On: 05/04/2022 10:04:11 AM
Post# of 10156
Posted By: russkitrader2018
During the interview Mr. Carrick updated current and prospective shareholders on recent milestones achieved by the Company including:

Nascent is at the leading edge of natural, patient-derived monoclonal antibody development with the Company's PTB monoclonal antibody solution benefitting from a well-defined regulatory and clinical development strategy toward the treatment of deadly brain cancers.

The vaccine development platform, using A recombinant Bacillus Calmette-Guerin (r-BCG), continues to progress and is intended to be used against viruses around the world.

https://www.accesswire.com/699981/Nascent-Bio...-Investors

(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site